Bioactive Compounds
-
BA2285 ArbemnifosbuvirSummary: Arbemnifosbuvir is a nucleovirus RdRp-associated nucleotide group transferase (NiRAN) nonstructural protein 12 (nsp12) interfering drug. -
N1683 Epimedin A -
BA2284 BofutrelvirSummary: Bofutrelvir (FB2001) is a major protease inhibitor of SARS-CoV-2. -
N1664 Nomilin -
BA2283 MM3122Summary: MM3122 is a selective inhibitor of type II transmembrane serine proteases. -
N1653 CrocinSummary: Natural carotenoid found in saffron -
BA2282 YH-53Summary: YH-53 is a potent inhibitor. -
N1633 Eleutheroside E -
BA2281 BamlanivimabSummary: Bamlanivimab (Anti-HumanSARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020. -
N1606 Prim-O-glucosylcimifugin
